DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Repligen Corporation (RGEN)
« Back to company indexRGEN Chatter Timeline
Stock Ticker for RGEN
Most Active Tweeters for RGEN
No tweets foundRecent Tweets for RGEN
 |
@WatchlistN Repligen $RGEN Reaches New 12-Month High at $50.86 https://t.co/LhH4n5AMbM August 21st 2018, 8:08pm |
 |
@MScreener Repligen Corporation: The stock is testing its highs. $RGEN https://t.co/qfZ4dLpsq5 https://t.co/K9ksQgHU4x August 21st 2018, 2:08pm |
 |
@ZolmaxNews Brokerages Expect Repligen Co. $RGEN Will Post Quarterly Sales of $46.43 Million https://t.co/e6Bh79VQXv August 21st 2018, 7:08am |
 |
@ConsumerFeed Repligen Co. $RGEN Given Average Recommendation of “Buy” by Brokerages https://t.co/gjK7BSSuBM August 20th 2018, 5:08pm |
 |
@AmericanBanking Analysts Expect Repligen Co. $RGEN Will Announce Earnings of $0.18 Per Share https://t.co/YQJTBV8LlN #stocks August 19th 2018, 12:08pm |
 |
@TickerReport Analysts Expect Repligen Co. $RGEN Will Announce Earnings of $0.18 Per Share https://t.co/c0jVxC2wu7 August 19th 2018, 12:08pm |
 |
@dailypoliticaln Repligen Co. $RGEN Expected to Post Earnings of $0.18 Per Share https://t.co/ScSgFUIIJm August 19th 2018, 12:08pm |
 |
@EnterpriseLeade Repligen $RGEN Posts Earnings Results, Misses Expectations By $0.02 EPS https://t.co/LtWKO2gx4F August 19th 2018, 8:08am |
 |
@usindexlive Nicholas Investment Partners LP Raised Repligen $RGEN Position; Schwab Charles Investment Management Increased Its… https://t.co/khfDjanv4J August 19th 2018, 5:08am |
 |
@TheMarketsDaily Repligen Co. $RGEN Receives $46.83 Consensus Target Price from Brokerages https://t.co/ZhU9Dffw9w August 18th 2018, 2:08pm |
 |
@MareaInformativ Repligen Co. $RGEN Receives $46.83 Consensus Target Price from Brokerages https://t.co/KwZvzHMZaH August 18th 2018, 1:08pm |
|
@MareaInformativ Repligen Co. $RGEN Given Consensus Recommendation of “Buy” by Brokerages https://t.co/9quXkkWo4j August 18th 2018, 5:08am |
|
@MareaInformativ Repligen $RGEN Releases FY18 Earnings Guidance https://t.co/D4t1MOgbUu August 17th 2018, 5:08pm |
|
@usindexlive Repligen $RGEN Share Value Rose While North Star Asset Management Lifted Its Stake; As Oracle $ORCL Share Value Dec… https://t.co/9A5RMTHyZR August 17th 2018, 4:08pm |
 |
@registrarjourn $46.43 Million in Sales Expected for Repligen Co. $RGEN This Quarter https://t.co/XXYjwQH2UR August 16th 2018, 9:08pm |
 |
@OlympiaReport Repligen Co. $RGEN Receives Consensus Recommendation of “Buy” from Brokerages https://t.co/62LNF0tghY August 15th 2018, 5:08am |
|
@AmericanBanking Repligen Co. $RGEN Receives Consensus Recommendation of “Buy” from Analysts https://t.co/FV4OglIIuj #stocks August 15th 2018, 5:08am |
 |
@dispatchtribune Repligen Co. $RGEN Receives Consensus Recommendation of “Buy” from Analysts https://t.co/kv8pZ6eisW August 15th 2018, 5:08am |
|
@OlympiaReport Analysts Offer Predictions for Repligen Co.’s Q3 2018 Earnings $RGEN https://t.co/asMvTYU5nZ August 15th 2018, 2:08am |
 |
@WeekHerald Analysts Offer Predictions for Repligen Co.’s Q3 2018 Earnings $RGEN https://t.co/Ak3Fwnpwy8 August 15th 2018, 2:08am |
 |
@filing_scanner $RGEN New Insider Filing On: EDDLEMAN ROY T Transaction Code: S https://t.co/VjknAU4GUs August 14th 2018, 2:08pm |
 |
@beyond_ninety North Star Asset Management Continues to Hold Stake in Repligen $RGEN; Starbucks $SBUX Stock Price Rose While Fagan… https://t.co/SR2g7ZlOsv August 14th 2018, 11:08am |
|
@TickerReport Brokers Set Expectations for Repligen Co.’s Q3 2018 Earnings $RGEN https://t.co/1safzj4mxJ August 14th 2018, 2:08am |
|
@dailypoliticaln Brokers Set Expectations for Repligen Co.’s Q3 2018 Earnings $RGEN https://t.co/kBXdkwlWUW August 14th 2018, 2:08am |
 |
@InsiderAlertsIA $RGEN: New Insider Filing on 10%+ Owner EDDLEMAN ROY T: https://t.co/JBznuLyocM August 13th 2018, 4:08pm |
 |
@RTFilingsStocks EDDLEMAN ROY T files Form 4 for $RGEN Sold 116073 shares Price range: $49.5395-49.674 Transaction Dates: 8/9/2018-8… https://t.co/ywWy3OH7Aq August 13th 2018, 4:08pm |
|
@AmericanBanking Equities Analysts Issue Forecasts for Repligen Co.’s Q3 2018 Earnings $RGEN https://t.co/cZ3zIg3RIe #stocks August 13th 2018, 2:08am |
|
@TheMarketsDaily Equities Analysts Issue Forecasts for Repligen Co.’s Q3 2018 Earnings $RGEN https://t.co/jm4Ppb6Zc8 August 13th 2018, 2:08am |
|
@MareaInformativ Repligen $RGEN Given New $56.00 Price Target at Citigroup https://t.co/oGnzTt582L August 13th 2018, 2:08am |
 |
@SwingTradeBot Recent $RGEN technical alerts: Calm After Storm plus 11 more alerts... https://t.co/a70lse8CS9 August 12th 2018, 9:08am |
 |
@1MinuteStock We calculated 21-day Expected Return of $RGEN for you: 2.84% https://t.co/uEW12iS2bz August 12th 2018, 8:08am |
|
@usindexlive Douglass Winthrop Advisors Lifted Its Cbs Cl B New $CBS Holding; Shorts at Repligen $RGEN Lowered By 1.06% https://t.co/AOwv8etC7Q August 12th 2018, 8:08am |
|
@1MinuteStock Do you know that #WallStreet price for $RGEN is $46.8 https://t.co/GOpLVwOEx9 August 12th 2018, 7:08am |
 |
@bibeypost_stock Is Buying Repligen Corporation $RGEN, Having Higher Short Interest a Winning Strategy? - https://t.co/tDn0tOy6N8 August 12th 2018, 7:08am |
 |
@mmahotstuff1 Repligen Corporation $RGEN Can't Be More Risky. Short Interest Increased - https://t.co/JdZ767kDFQ August 12th 2018, 7:08am |
 |
@reurope_stock Is Buying Repligen Corporation $RGEN Here Good Idea? https://t.co/9Q5fKlbkgv August 12th 2018, 7:08am |
 |
@whatsonthorold2 After Reaching Milestone, Is Repligen Corporation $RGEN’s Short Interest Revealing Something? - https://t.co/D5FZDGVoBk August 12th 2018, 7:08am |
 |
@west_moreland Could Repligen Corporation $RGEN Change Direction After More Shorts? https://t.co/rvTqieSOHt August 12th 2018, 7:08am |
 |
@Fanob_stock Time to Reconsider Repligen Corporation $RGEN After More Short Sellers? https://t.co/bhBvXphMPN August 12th 2018, 7:08am |
|
@1MinuteStock Wondering about risks of $RGEN? The 63-day volatility is 9.52% https://t.co/WsC6wXEGQi August 12th 2018, 7:08am |
|
@MareaInformativ UBS Group AG Has $2.13 Million Position in Repligen Co. $RGEN https://t.co/JIJjcCWcT9 August 11th 2018, 10:08pm |
|
@TickerReport Repligen $RGEN Lowered to “Sell” at Zacks Investment Research https://t.co/Hai36CmQ64 August 11th 2018, 2:08pm |
|
@WatchlistN Repligen $RGEN Lowered to “Sell” at Zacks Investment Research https://t.co/DVjAaUi0Jd August 11th 2018, 2:08pm |
|
@EnterpriseLeade Repligen $RGEN Issues Earnings Results, Misses Expectations By $0.02 EPS https://t.co/LtWKO2gx4F August 11th 2018, 1:08pm |
|
@usindexlive Nikko Asset Management Americas Boosted Apple $AAPL Position; Ranger Investment Management LP Cut Repligen $RGEN Po… https://t.co/kQrxf1Us9w August 11th 2018, 8:08am |
|
@TheMarketsDaily Roy T. Eddleman Sells 33,142 Shares of Repligen Co. $RGEN Stock https://t.co/fB4zvfbxzP August 11th 2018, 5:08am |
|
@WeekHerald Repligen $RGEN Cut to Sell at Zacks Investment Research https://t.co/DVqED1T8JH August 10th 2018, 3:08pm |
 |
@bbnsnews Repligen $RGEN Downgraded by Zacks Investment Research to Sell https://t.co/BsB3YonRj0 August 10th 2018, 1:08pm |
|
@TheMarketsDaily Roy T. Eddleman Sells 4,770 Shares of Repligen Co. $RGEN Stock https://t.co/z4J54bpSoN August 10th 2018, 8:08am |
|
@MareaInformativ Repligen $RGEN Updates FY18 Earnings Guidance https://t.co/D4t1MOgbUu August 10th 2018, 12:08am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2018. All rights reserved.